What is Phi Life Sciences?
Phi Life Sciences is a molecular diagnostic and laboratory services company headquartered in Charleston, South Carolina. The company specializes in a broad spectrum of clinical diagnostic services, including advanced testing for infectious diseases, cancer genomics, and medication management. Their commitment to precision medicine extends to offering genetic counseling and clinical trial services, aiming to empower healthcare providers and patients with actionable insights. As a registered point-of-care provider, Phi Life Sciences also facilitates rapid antigen testing, demonstrating its adaptability and reach within the healthcare ecosystem.
How much funding has Phi Life Sciences raised?
Phi Life Sciences has raised a total of $317K across 2 funding rounds:
Debt
$150K
Debt
$167K
Debt (2020): $150K with participation from PPP
Debt (2021): $167K led by PPP
Key Investors in Phi Life Sciences
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Phi Life Sciences?
With substantial backing at this late stage, Phi Life Sciences is poised for significant expansion and further innovation in its service offerings. The strategic investment will likely fuel advancements in their precision medicine solutions, potentially broadening their diagnostic capabilities and market penetration. Future growth may involve scaling laboratory operations, enhancing technological infrastructure, and forging new partnerships within the healthcare industry to solidify their role as a key provider of comprehensive diagnostic services.
See full Phi Life Sciences company page
